Additional presentations highlight the design of an ongoing Phase 3 study evaluating tenapanor in chronic idiopathic constipation and the impact of IBS-C symptom burden on quality of life
Ute Indian Tribe Mosquito Abatement Department to bring PCR-based mosquito surveillance testing in house
Ebola Assay in Development for Decentralized Testing on the Co-Dx PCR Platform
New Executive Order prioritizes improved detection and calls for federal R&D programs for rapid diagnostics for mosquito- and tick-borne diseases
BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
Agreement supports significant investments in U.S. manufacturing, strengthens healthcare resilience and increases domestic production of essential medical consumables used in approximately 90% of U.S. hospital visits
DiscGenics Announces Leadership Transition as IDCT Advances Through Pivotal Phase III Development
Cell-of-origin insights could deepen understanding of CNS injury and disease progression in multiple sclerosis and related diseases
Medical Product Outsourcing hosts the MPO Summit each year at destinations rich in medical device manufacturing. They held their annual Summit on October 7-8 at the Grand America Hotel in Salt Lake City. In doing so, they recognized the significant national role Utah plays in the manufacturing of medical devices. Kelvyn Cullimore, CEO of BioUtah, […]
$1M federal award supports groundbreaking research on rare childhood neurological disorder while expanding student research opportunities.
Integration brings AI-powered vocal analysis into VillageFor’s maternal mental health platform as demand grows for more continuous support throughout the motherhood journey.
This year’s Innovation Award recipients are redefining what’s possible for some of society’s biggest challenges.
Nucleus Institute Convergence Point Groundbreaking
The First Surgical Pulmonary Valve for Pediatric Patients.
Expands Company’s Portfolio of Advanced Neurovascular Catheters to Support Treatment in Smaller and More Distal Anatomies.
National coalition led by the maker of the first and only FDA-cleared smart baby monitor on the market invites the community to join and amplify baby safety awareness efforts
Generations of Utah employees have helped ensure the reliable supply of essential medical devices that clinicians use every day to care for patients around the world.
Financing provides capital to advance Freyya’s technology through the next regulatory milestones and toward building a foundation for commercialization.
It is with great sadness and a heavy heart that we inform you that our former Managing Director and company founder, Dr. Michael Rinck, passed away on September 10, 2026, at the age of 73. Dr. Michael Rinck founded our company in 1995 and, over many decades, shaped it with immense dedication, vision, and […]
bioMérieux Launches SPINCHIP® hs-cTnl, a Major Innovation for the Measurement of High-Sensitivity Cardiac Troponin I and Faster Management of Cardiac Emergencies
PDUFA target date set for March 16, 2027, following positive phase 3 results
National Institutes of Health Award Inherent Biosciences a Direct-to-Phase II SBIR Grant
Roundtable discussion, taking place in New York City, will examine the ongoing Ebola outbreak and technologies needed to strengthen future outbreak response.
Epitel’s REMI Neuro Monitoring System Selected for the FDA’s READI-Home Innovation Challenge
PARTICIPANT TESTS DIRECT NERVE INTERFACE OF THOUGHT-CONTROLLED “LUKE ARM” AT HOME
Thanks to all who joined us andt sponsored the event! Be sure to check out our event gallery!
Reinstein brings medtech and epilepsy experience as the company expands REMI® and enters its next stage of growth.
Study informed by encouraging exploratory efficacy findings and a favorable safety profile in the prior Phase 3 trial.
Investment led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s CEO and other existing shareholders.
Blood-based testing could open new markets for the Co-Dx® PCR platform, including HIV and hepatitis B and C.
Vishal Sikri has been promoted to Executive Vice President – Commercial, effective September 16, 2026.
